Clinical stage, novel peptide-drug conjugates (PDCs) and nanobody-drug conjugates (NDCs) with BIC/FIC potential for challenge target in oncology. 

Contact Us

Tel: 021-33670826
E-mail: Info@conjustar.com
Add: 3rd Floor, Building 2, 367 Shengrong Road, Pudong New Area, Shanghai